What is razor blade throat? New Covid variant ‘Nimbus' causing very painful symptom, know about prevention
A new COVID-19 variant, called NB.1.8.1, might be behind nearly a third of new cases, according to health officials. This variant, which some people are calling 'Nimbus,' is getting attention because of one painful symptom—something people are now describing as 'razor blade throat.'
The Centers for Disease Control and Prevention (CDC) says Nimbus made up about 37% of COVID-19 cases in the US in the two weeks ending June 7.
Experts believe Nimbus spreads more easily, but doesn't seem to cause more severe illness, as cited by Fox news report.
Also Read: What is 'Nimbus'? New COVID variant spreading in THESE 14 US states, know symptoms here
People who have caught the Nimbus variant have described having a really bad sore throat — some say it feels like swallowing broken glass. Doctors say the pain can get so bad that it's hard to talk, eat, or even drink water. While sore throats have always been a symptom for some COVID-19 patients, this variant is causing throat pain that's much more intense than usual.
If you're dealing with a sore throat caused by the Nimbus variant, there are a few things you can try to feel better:
Over-the-counter medicine: Pain relievers like acetaminophen (Tylenol) or ibuprofen (Advil) can help reduce throat pain and swelling.
Saltwater gargle: Gargling warm salt water can help soothe your throat and might lower the amount of virus in your mouth.
Throat lozenges and sprays: Look for ones with menthol or benzocaine. These can numb the throat and bring short-term relief.
Stay hydrated: Drinking warm liquids like tea or broth can keep your throat moist and ease the pain.
Use a humidifier: Adding moisture to the air can help prevent your throat from getting dry and irritated.
These home remedies can help, but it's important to keep an eye on your symptoms. If your sore throat doesn't get better or gets worse, call your doctor.
The Nimbus variant often causes a sore throat, but most people only get mild symptoms. Still, some signs mean you should get medical help:
Your symptoms don't go away or start to get worse
You're having trouble breathing or feel tightness in your chest
You have a high fever (over 100°F) that lasts for several days
You can't drink enough fluids because your throat hurts too much, and you start feeling dehydrated
Older adults, pregnant people, or anyone with other health issues should talk to a doctor right away if they get sick.
To lower your chances of catching the Nimbus variant, follow these basic COVID-19 safety steps:
Wear a mask in crowded places or indoor spaces
Wash your hands with soap and water for at least 20 seconds
Keep your distance from people who are sick
Get vaccinated and stay up-to-date on COVID-19 shots to help protect yourself from serious illness
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Southern Railway launches telemedicine link to bring specialist care to remote railway units
SR general manager R N Singh inaugurated the telemedicine facility. CHENNAI: Southern Railway has launched an integrated telemedicine facility in railway hospitals and health units, allowing patients in remote areas to access specialist and super-specialist care without travelling long distances. Inaugurated by general manager R N Singh at the Southern Railway Headquarters Hospital in Perambur on Friday, the system links divisional hospitals and health units to the headquarters hospital here. The facility was developed under the Government of India's e-Sanjeevani scheme. Using real-time video consultations and live streaming of diagnostic reports such as ECGs and X-rays, medical officers at remote locations can now consult directly with specialists at Perambur, streamlining treatment decisions. Officials said the facility proved crucial during the Covid-19 pandemic and is now the first of its kind in Indian Railways. During the launch, Singh witnessed a live consultation from the Divisional Railway Hospital in Madurai and urged officials to ensure high-speed internet across all health units. He reviewed new digital queue systems and signage boards at the Perambur OPD block.
Hans India
4 hours ago
- Hans India
Airborne fungal spores may help predict Covid, flu surge: Study
New Delhi: Monitoring fungal spores in the outdoor air can predict surges in flu and Covid-19 infections, according to a study. Researchers from Lynn University in Florida, US, discovered that airborne concentrations of fungal spores -- but not pollen -- were strongly linked to increases in flu and Covid-19 cases. When airborne concentrations of fungal spores rose, the scientists often saw a jump in infections within a few days. The study models were able to predict flu and Covid-19 surges with high accuracy, particularly in the fall season. However, pollen didn't show the same connection or prediction. 'The findings from our study suggest that monitoring airborne fungal spore levels could help predict short-term outbreaks (spikes) of flu and Covid-19, giving public health systems an early warning signal,' said Felix E. Rivera-Mariani, Associate Professor of Biochemistry at Lynn. 'Our findings also highlight the potential role of environmental factors -- not just person-to-person spread -- in contributing to the incidence of respiratory viral infections. That could open new doors for targeted public health alerts, especially in areas with high outdoor airborne fungi," Rivera-Mariani added. In the study, the team examined daily data from 2022 to 2024, in two major health regions in Puerto Rico—San Juan and Caguas. The data included the daily incidence of people diagnosed with Covid-19 and flu, and the concentrations of airborne fungal spores and pollen recorded on the same days. The scientists then implemented statistical and machine learning models to see if high levels of these environmental exposures could predict spikes in flu and Covid-19 cases within the same week or the following week (called lag-effect). 'The findings may help inform environmental risk alerts, particularly for vulnerable populations like the elderly or those with asthma and allergic rhinitis,' Rivera-Mariani said. The study was presented at ASM Microbe 2025 in Los Angeles, the annual meeting of the American Society for Microbiology.
The Hindu
5 hours ago
- The Hindu
What you need to know about the ‘razor blade' Covid variant
Covid-19, it seems, can never stay out of the news for very long. One variant of the virus has been making headlines recently for being behind a spike in cases, particularly in China and the United States, and for causing 'razor blade' throats, or a severely painful sore throat. What do you need to know about this? Read on, to find out. The 'razor blade' throat, reports indicate, is being caused by the NB.1.8.1 variant of the virus, an Omicron-descendent variant dubbed as 'Nimbus' and currently accounting for a large number of cases worldwide. On May 23, 2025, the World Health Organization classified this variant as a 'SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally, while LP.8.1 is starting to decline.' A technical document by the WHO states: 'Considering the available evidence, the additional public health risk posed by NB.1.8.1 is evaluated as low at the global level. Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease. Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Symptoms remain similar to those caused by other Covid-19 strains and include fever, a sore throat, cough, runny nose and tiredness. Media reports indicate some patients complaining of a sharp, stabbing pain while swallowing, often at the back of the throat, akin to 'swallowing a razor blade'. However, it is unclear if this is a distinctive symptom of this variant The WHO, in its technical document, had said spike mutations in this variant could increase its transmissibility. In India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), one case of NB.1.8.1 was identified in April in Tamil Nadu and four cases of LF.7 were detected in Gujarat in May. As of May, the most common variant remained JN.1, comprising 53 % of samples tested, followed by BA.2 (26 %) and other Omicron sublineages (20 %). In June, a media report stated about 163 cases of the COVID-19 variant XFG, had been detected, according to INSACOG data. Earlier this week, Naveen Kumar, Director, National Institute of Virology (NIV), Pune, said surveillance and genome sequencing have been scaled up. He said genomic analysis had revealed the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and that since May 2025, it had been replaced by the XFG (LF.7 and LP.81.2) recombinant variant. Doctors in India have reiterated that Covid-19 is now co-circulating with other seasonal infections and that they do not expect any major waves of the kind seen in 2021 and 2021. Spikes and dips however, may continue. Personal protection and hygiene measures such as hand washing, avoiding crowded places when possible or masking up, and protecting vulnerable segments of the population must continue, they have said. As of Friday, June 20, 2025, India's tally of active Covid-19 cases dipped to 5,608 from the 7,000 plus mark last week, and four new deaths were reported, taking the total toll this year to 120.
